{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:19:13Z","timestamp":1777763953589,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I3089-B28"],"award-info":[{"award-number":["I3089-B28"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013699","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft und Forschung","doi-asserted-by":"publisher","award":["GZ2020-0 .686.607"],"award-info":[{"award-number":["GZ2020-0 .686.607"]}],"id":[{"id":"10.13039\/501100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009968","name":"Tiroler Wissenschaftsf\u00f6rderung","doi-asserted-by":"publisher","award":["F.16950\/5\\u20132019"],"award-info":[{"award-number":["F.16950\/5\\u20132019"]}],"id":[{"id":"10.13039\/501100009968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ygyno.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T22:18:52Z","timestamp":1642025932000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dubious effects of methadone as an \u201canticancer\u201d drug on ovarian cancer cell-lines and patient-derived tumor-spheroids"],"prefix":"10.1016","volume":"165","author":[{"given":"Heidelinde","family":"Fiegl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Hagenbuchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiana","family":"Kyvelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sieghart","family":"Sopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Tsibulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Wieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Huhtinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Carp\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walther","family":"Parson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Marth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ausserlechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain G.","family":"Zeimet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.01.008_bb0005","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10354-018-0623-5","article-title":"Methadone as anticancer treatment: hype, hope, or hazard?\u202f: A series of case reports and a short review of the current literature and recommendations of the societies","volume":"168","author":"Kreye","year":"2018","journal-title":"Wien Med Wochenschr."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bcp.12051","article-title":"Pharmacological maintenance treatments of opiate addiction","volume":"77","author":"Bell","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1978.tb16767.x","article-title":"Use of psychotropic drugs in treatment of methadone maintained narcotic addicts","volume":"311","author":"Kleber","year":"1978","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","article-title":"Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine","volume":"909","author":"Kreek","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1978.tb16769.x","article-title":"Medical complications in methadone patients","volume":"311","author":"Kreek","year":"1978","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0035","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4161\/cc.28493","article-title":"Opioid receptor activation triggering down-regulation of camp improves effectiveness of anti-cancer drugs in treatment of glioblastoma","volume":"13","author":"Friesen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.18632\/oncotarget.952","article-title":"Cell death sensitization of leukemia cells by opioid receptor activation","volume":"4","author":"Friesen","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0045","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-08-1227","article-title":"Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance","volume":"68","author":"Friesen","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.rbmo.2015.12.006","article-title":"Opiate receptor blockade on human granulosa cells inhibits VEGF release","volume":"32","author":"Lunger","year":"2016","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0055","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.rbmo.2012.02.007","article-title":"Expression and localization of opioid receptors during the maturation of human oocytes","volume":"24","author":"Agirregoitia","year":"2012","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2017.01.020","article-title":"Mu opioid receptor in the human endometrium: dynamics of its expression and localization during the menstrual cycle","volume":"107","author":"Totorikaguena","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","article-title":"DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination","volume":"127","author":"Korch","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0075","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41598-017-01624-4","article-title":"DNA methylation and transcriptome changes associated with cisplatin resistance in ovarian cancer","volume":"7","author":"Lund","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1096\/fj.04-3062fje","article-title":"Cancer cell-line identification by short tandem repeat profiling: power and limitations","volume":"19","author":"Parson","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0085","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1038\/onc.2017.288","article-title":"FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3","volume":"36","author":"Rupp","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0095","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/0008-5472.CAN-09-3551","article-title":"E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer","volume":"70","author":"Reimer","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.2011.510","article-title":"Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients","volume":"106","author":"Goebel","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0105","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108027","article-title":"Comparison of human antral follicles of xenograft versus ovarian origin reveals disparate molecular signatures","volume":"32","author":"Man","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0115","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting Signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0120","doi-asserted-by":"crossref","first-page":"26815","DOI":"10.1074\/jbc.272.43.26815","article-title":"Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate","volume":"272","author":"Chuang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0026-895X(25)09321-6","article-title":"The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express \u03bc-opioid receptors","volume":"50","author":"Li","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0169-328X(00)00002-4","article-title":"Opioid receptor endocytosis and activation of MAP kinase pathway","volume":"76","author":"Trapaidze","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1471-4159.2000.740564.x","article-title":"Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen- activated protein kinase signaling cascade","volume":"74","author":"Bohn","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1747-0285.2009.00875.x","article-title":"The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line","volume":"74","author":"Gach","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091577","article-title":"The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer","volume":"9","author":"Lennon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.01.008_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygyno.2022.01.008_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymthe.2005.06.479","article-title":"Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis","volume":"13","author":"Cheng","year":"2006","journal-title":"Mol. Ther."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:57:52Z","timestamp":1777474672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0090825822000099"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.01.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dubious effects of methadone as an \u201canticancer\u201d drug on ovarian cancer cell-lines and patient-derived tumor-spheroids","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}